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The antioxidative activity of ferrocenes bearing either 2,6-di-tert-butylphenol or phenyl groups has been compared using DPPH
(1,1-diphenyl-2-picrylhydrazyl) test and in the study of the in vitro impact on lipid peroxidation in rat brain homogenate and
on some characteristics of rat liver mitochondria. The results of DPPH test at 20
◦C show that the activity depends strongly upon
the presence of phenolic group but is improved by the inﬂuence of ferrocenyl fragment. The activity of N-(3,5-di-tert-butyl-
4-hydroxyphenyl)iminomethylferrocene (1), for instance, was 88.4%, which was higher than the activity of a known antioxidant
2,6-di-tert-butyl-4-methylphenol(BHT)(48.5%),whereas theactivity ofN-phenyl-iminomethylferrocene2was almostnegligible
−2.9%.Thedataobtaineddemonstratethatthecompoundswith2,6-di-tert-butylphenolmoietyaresigniﬁcantlymoreactivethan
the corresponding phenyl analogues in the in vitro study of lipid peroxidation in rat brain homogenate. Ferrocene 1 performs
a promising behavior as an antioxidant and inhibits the calcium-dependent swelling of mitochondria. These results allow us to
proposethepotentialcytoprotective(neuroprotective)eﬀectofditopiccompoundscontainingantioxidant2,6-di-tert-butylphenol
group and redox active ferrocene fragment.
1.Introduction
Oxidative stress has been found to play a critical role in
numerous disease conditions including neurodegeneration
[1–3].
The antioxidative defense system in living organism
regulates a disturbance in the prooxidant-antioxidant bal-
ance and protects the cell damage induced by high level of
oxidative stress. Among the classes of well-known natural
antioxidants-vitamins E group, ascorbic acid, glutathione,
and so forth, α-tocopherol and its synthetic analogues,
sterically hindered phenols, are of particular importance
[4]. The substituted 2,6-dialkylphenols are widely used as
inhibitors of free radicals formation in the oxidative destruc-
tion of natural and synthetic substrates. The mechanism
of their physiological action is associated with the stable
phenoxylradicals’formationintheprocessofhydrogenatom
abstraction by highly reactive peroxyl radicals of lipids [5].
The goal of this study was to optimize the eﬀect
of 2,6-di-tert-butylphenol and to increase the stability of
the corresponding phenoxyl radicals responsible for their
antioxidative activity. The approach based on modiﬁcation
of phenolic antioxidants via incorporation of ferrocenyl
moiety in their molecules seems to be a promising one.
Previously we have reported the synthesis, electrochemical
characteristics, and ESR study of novel ferrocenes with redox
active 2,6-di-tert-butylphenol fragments (compounds 1,3)
[6]. These compounds exhibit the properties of multistep
redox systems, and the intramolecular electron transfer
between two redox active sites of the molecule (the phenol
and ferrocene groups) was observed. The high stability
of phenoxyl radical species formed in the oxidation is in
agreement with a certain degree of electronic delocalization
over the molecule.
On the other hand, the ferrocene derivatives show a wide
spectrum of physiological activity [7–9].
The incorporation of ferrocene into an anticancer drug
tamoxifen, a selective estrogen receptor modulator, contain-
ingphenolwasreported.Theactivityofthesenovelferrocene
derivatives (ferrocifens) was found to be associated with the2 Bioinorganic Chemistry and Applications
1 2
34
56
Fe
N Fe
N
Fe
O
Fe
But
OH
But
N
Fe N
But
OH
But
Fe
O
But
OH
But
Figure 1: Structures of compounds 1–6.
proton-coupled electron transfer between ferrocenium ion
and phenol group that occurs in their oxidized species [10–
12].
The antioxidative activity in scavenging of superoxide
radical-anionO
•−
2 andHO
• radicalwasobservedforrecently
synthesized ferrocenes containing nitroxides radicals as
substituents [13].
As it has been reported earlier, diselenides having redox-
active ferrocenyl units show peroxidase-like antioxidant
activity mimicking selenoenzyme glutathione peroxidase
that protects the cell membranes from oxidative damage
[14].
I no u rp r e v i o u ss t u d y ,w eh a v eo b s e r v e dt h em o d u l a t i o n
of the antioxidative eﬀect of metalloporphyrins bearing 2,6-
di-tert-butylphenol pendants by the metal nature [15].
In this study we compared the antioxidative activity of
1–6 presenting the pairs of compounds bearing either 3,5-
di-tert-butyl-4-hydroxyphenyl or phenyl substituents linked
to the ferrocene by various spacers (Figure 1).
2.MaterialsandMethods
2.1. Ferrocenes. N-(3,5-di-tert-butyl-4-hydroxyphenyl)-imi-
nomethylferro-cene (1), N-phenyl-iminomethylferrocene
(2), N-(3,5-di-tert-butyl-4-hydroxybenzyl)-iminomethylfer-
rocene (3), N-benzyliminomethylferrocene (4), (3,5-di-tert-
butyl-4-hydroxyphenyl)-3-ferrocenylpropen-2-on (5), and
phenyl-3-ferrocenylpropen-2-on (6) were synthesized as
described previously [6, 16].
2.2. DPPH Radical Scavenging Activity. The free radical-
scavenging activity was evaluated using the stable radical
DPPH, according to the method described by Brand-
Williams et al. [17] with a slight modiﬁcation.
Each compound was tested for antioxidant activity
against DPPH radical at a molar 1:1 ratio. One mL of
antioxidant solution in methanol was added to 1mL of
DPPH solution in methanol so that the ﬁnal DPPH and
antioxidant concentration can be 0.1mM. The samples
were incubated for 30 minutes at 20◦C in methanol and
the decrease in the absorbance of DPPH solution was
measured at 517nm, using a Thermo Evolution 300BB
spectrophotometer. The results were expressed as scavenging
activity, calculated as follows:
Scavenging activity,% =
(A0 −A1)
A0

× 100. (1)
The concentration of antioxidant needed to decrease
50% of the initial substrate concentration (EC50)i sa
parameterwidelyusedtomeasuretheantioxidanteﬀect[18].
For determination of EC50, the values of DPPH solutionBioinorganic Chemistry and Applications 3
absorbance which decrease after 30 minutes were used. The
EC50 values were calculated graphically by plotting scaveng-
ing activity against compound concentration. Diﬀerent sam-
ple concentrations (0.01, 0.02, 0.05, and 0.1mM) were used
in order to obtain kinetic curves and to calculate the EC50
values.ThelowerEC50 meansthehigherantioxidantactivity.
2.3. Rat Brain Homogenates (RBH) and Rat Liver Mitochon-
dria(RLM)Preparation. Onthedayoftheexperiment,adult
Wistar male rats fasted overnight were euthanized in a CO2-
chamber followed by decapitation. The procedure was in
compliance with the Guidelines for Animal Experiments at
Institute of Physiologically Active Compounds of Russian
Academy of Sciences.
The brains were rapidly removed and homogenized in
0.12M HEPES/0.15M NaCl, pH 7.4 buﬀer (HBS) (10mg/gr
wet weight) and used immediately for assay.
Mitochondria were isolated from homogenates of livers
of adult Wistar strain rats, fasted overnight, in a 5mM
HEPES buﬀer, pH 7.4, containing 210mM mannitol, 70mM
sucrose, and 1mM EDTA, by conventional diﬀerential cent-
rifugation [19].
P r o t e i nc o n c e n t r a t i o n si nR B Ha n dR L Mw e r ed e t e r -
mined by the biuret assay using bovine serum albumin as a
standard [20].
2.4. Fe3+-Induced Lipid Peroxidation Assay. The extent of
lipid peroxidation (LP) was estimated by the levels of
malondialdehyde measured using the thiobarbituric acid
reactive substances (TBARS) assay. Isolated mitochondria
are metabolically active and tightly coupled as shown by
respiratory control ratio values, which were about 4 with
glutamate-malate as substrate as measured by mitochondrial
oxygen consumption at Oroboros oxygraph (Anton Paar,
Austria) in a medium containing 10mM KH2PO4 (or
NaH2PO4), 60mM KCl, 60mM Tris, 5mM MgCl2, 110
mannitol, and 0.5mM EDTA-Na2,p H7 . 4 .
Study of compounds inﬂuence on LP of the RBH was
carried out at 30◦C for 40 minutes in 0.25mL of the RBH
in HBS (2mg of protein·mL−1) in the presence or absence
of compounds or vehicle (DMSO). LP was induced by using
Fe3+ (0.5mM Fe(NH4)(SO4)2) as an oxidizing agent [21].
Then 0.25mL aliquots were mixed with 0.5mL thiobarbi-
turic acid (TBA) medium containing 250mM HCl, 15%
trichloroacetic acid, and 3mM TBA, heated at 95◦Cf o r1 5
minutes, cooling at 4◦Ct h e np r o b e sc e n t r i f u g e d( 1 0m i n u t e s
at 10000g) and the supernatants transferred into 96-plate
and absorbance was measured at 530–620nm at the Wallac
Victor 1420 Multilabel Counter (PerkinElmer Wallac).
All the experiments were performed using four indepen-
dent experiments with diﬀerent brain homogenate prepara-
tions. Data are normalized to control probe with oxidant as
100% and blank probe with diluent but without oxidizing
agent. Preliminary experiments were done in the absence
of compounds interaction with thiobarbituric acid. The
v a l u e sa r ee x p r e s s e da sm e a n %± SD. The concentrations of
ferrocenes giving half-maximal inhibition (IC50)o fL Pw e r e
determined by dose-eﬀect analysis.
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Figure 2: Scavenging activity for compounds 1–6 in DPPH test
(MeOH, 20◦C, 100μM).
2.5. Mitochondrial Swelling Assay. Mitochondrial swelling
caused by inﬂux of solutes through open mitochondrial
permeability transition (MPT) pores results in an increase in
light transmission (i.e., a reduced turbidity). This turbidity
change oﬀers a convenient and frequently used assay of
the MPT by measurement of absorbance in mitochondrial
suspensions. The MPT induced by Ca2+ was monitored
by absorbance changes at 540nm in a Beckman DU 640
spectrophotometerin1mLofbuﬀerAplus0.8μMr otenone,
5mM succinate, 1mM KH2PO4, and 0.5mg protein of
isolated liver mitochondria at 30◦C and continuous stirring
[19]. Swelling rate is quantiﬁedas ΔA540/min/mg, calculated,
in all cases, from a tangent to the steepest portion of the plot
of A540 versus time.
2.6. Measurement of Mitochondrial Membrane Potential. The
same experimental conditions were used for the assessment
of alterations of the mitochondrial membrane potential,
except that safranine was included in incubation medium
at a ﬁnal concentration of 10μM and succinate was added
after the compound. This concentration of safranine was
determined before hand as the optimal compromise between
signal/baseline ratio and interference of safranine itself with
swelling induced by Ca/Pi (safranine tended to enhance
Ca/Pi-induced swelling at concentrations above 20μM)
[19]. Changes in the status of the MPT pore are assessed
spectrophotometrically at 524 versus 554nm in a Beckman
DU 640 spectrophotometer at 30◦C and continuous stirring.
3. Results and Discussion
We have compared the antioxidative activity of 1–6 pre-
senting the pairs of compounds bearing either 3,5-di-tert-
butyl-4-hydroxyphenyl or phenyl substituents linked to the
ferrocene by various spacers (Figure 1).
The scavenging activity has been studied in the process
of hydrogen atom transfer to the stable free radical DPPH4 Bioinorganic Chemistry and Applications
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Figure 3: The relative content of TBARS in the lipid peroxidation
of rat brain homogenates as nonenzymatic process in the presence
of 10 μM 1–6 (0.5mM Fe(NH4)(SO4)2).
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Figure 4: Inﬂuence of 0.1mM ferrocenes 1and 2on mitochondrial
swelling and transmembrane potential (the values were determined
and expressed as % of control).
[22]. The results of DPPH test at 20◦C show that the
activity depends strongly upon the presence of phenolic
group in the presented pairs of compounds. The activity
of 1, for instance, was 88.4% that is higher than that
of a known antioxidant 2,6-di-tert-butyl-4-methylphenol
(BHT) (48.5%) whereas the activity of 2 bearing phenyl
substituent was almost negligible −2.9% (Figure 2). The
values of scavenging activity of compounds 3, 5 were lower,
and in the case of 3 the decrease in activity was more
pronounced. Evidently the activity extent of the compounds
tested depends on their molecular structures. The HO-group
of 2,6-di-tert-butylphenol is the key site in the molecule that
is involved in hydrogen transfer to DPPH. However, despite
the presence of ferrocene moiety in all the compounds
Table 1: The values of IC50 in the antioxidative activity assay in rat
brain homogenates for compounds 1–6.
Compound IC50 μM( 0 . 5m MF e ( N H 4)(SO4)2)
13 . 7 ± 1.0
2 70.4 ± 11.1
3 47.3 ± 2.4
4 100 ± 15.0
53 . 9 ± 1.8
6 47.8 ± 1.6
they diﬀer signiﬁcantly containing linkers of various length
and conjugation ability (–CH=N–, 1; –CH=N–CH2–, 2;–
CH=CH–C(O)–, 3). The decrease of conjugation in their
molecules containing either CH2 or CO groups in linkers
leads to the decrease of metal inﬂuence on the stability
of radicals formed as it has been observed previously [6].
However, it should be mentioned that the activity of 3
is much higher than that of 5 with N atom possessing a
lone electron pair in linker that improves the inﬂuence of
ferrocene moiety.
To compare the activity of compounds under investi-
gation with that of widely known antioxidant parameter,
EC50 was determined for the more eﬃcient ferrocene 1 and
2,6-d-tert-butyl-4-methylphenol (BHT). EC50values after 30
minutes of experiment at 20◦Cf o r1 and BHT are 34.6 and
105.4 μM, respectively. Therefore, the result obtained shows
am o r ep r o n o u n c e de ﬀect of ferrocenyl derivative of 2,6-di-
tert-butylphenol.
In order to study the antioxidant eﬀect of ferrocenes 1–
6 in biologically signiﬁcant in vitro test system, we have
investigated the compounds inﬂuence on Fe3+-induced per-
oxidationofbrainhomogenatelipids(LP)asanonenzymatic
process by addition of (NH4)Fe(SO4)2. The level of LP was
followed by the accumulation of products that reacted with
thiobarbituric acid—TBARS. The samples of Wistar strain
rats homogenates were divided as following: one control
homogenate and samples of homogenate with addition
of compounds under investigation. TBARS concentrations
were determined in homogenates by measuring the intensity
of the solution color at 530nm using UV-VIS spectroscopy
[23].
The data of antioxidative activity assay of 1–6 presenting
the pairs of compounds bearing either 3,5-di-tert-butyl-4-
hydroxyphenyl or phenyl substituents linked to the ferrocene
by various spacers are shown in Figure 3.T h eI C 50 values are
summarized in Table 1.
The data of antioxidative activity assay of ferrocenes 1–
6 indicate the inﬂuence of 2,6-di-tert-butylphenol group as
i tw a so b s e r v e di nD P P Ht e s t .F e r r o c e n e1 performs an
eﬀective inhibitory action in concentrations range at 10–
100μM( Figure 3, curve 1). The decrease in peroxidation
level is more that 10%.
In contrast to DPPH test, the data of this assay reveal the
antioxidant activity of all studied compounds. These results
allow us to suggest that the ferrocene moiety participates
in antioxidative potential of these compounds. However,Bioinorganic Chemistry and Applications 5
the compounds 1, 3, 5 bearing 2,6-di-tert-butylphenol are
signiﬁcantly more active than the corresponding phenyl ana-
logues. This eﬀect is most obvious at concentration 10μM
of compounds (Figure 3). Moreover, at this concentration
some pro-oxidant eﬀect of compounds 2 and 4 could be
observed. This fact might be associated with the inﬂuence of
iron center in the molecules of ferrocenes that participates in
redox processes and therefore promotes the peroxidation.
The involvement of ferrocene group in the peroxidation
process might be associated with the oxidation of Fe2+ to
Fe3+ in the oxidative medium that leads to the formation
of ferrocenium cation. As it was proved earlier [24]f e r -
rocenium cations react easily with molecular oxygen and
produce reactive peroxy radical cations. On the other hand,
in the presence of antioxidant, namely BHT, ferrocenium
cation can be stabilized due to the reduction that takes
place between the cation and antioxidant. The principal
consequence of this electron/proton coupled reaction is the
reversibility of ferrocene/ferrocenium redox system. This
fact might support the proposition of the intramolecular
redox process in ferrocene species containing 2,6-di-tert-
butylphenol fragment (compounds 1, 3, 5).
To study proapoptotic/antiapoptotic eﬀect of ferrocene
1 with 2,6-d-tert-butylphenol group which shows the more
promising activity in both tests and to compare it with
the eﬀect of its analog 2 bearing phenyl substituent, we
have investigated the inﬂuence of these compounds on
two main characteristics of mitochondria: calcium-induced
mitochondrial swelling (SW) that represents the mitochon-
drial permeability pores opening (which causes cell death),
and mitochondrial membrane potential.
It was shown that at concentration 0.1mM ferrocenes
1 and 2 slightly depolarize the mitochondria (up to 25%)
(Figure 4). On the other hand, these compounds inhibit
the calcium-dependent swelling of mitochondria and this
eﬀect could not be the consequence of the depolarisation
only. In both cases the eﬀects on mitochondrial swelling and
mitochondrial membrane potential obtained for ferrocene
1 a r el e s sp r o n o u n c e dt h a tf o r2. These data allow us to
propose the potential cytoprotective (neuroprotective) eﬀect
of compounds studied.
4. Conclusion
The antioxidative activity of ferrocenes bearing either 2,6-di-
tert-butylphenol or phenyl groups, studied using DPPH test,
depends strongly upon the presence of phenol group and the
conjugation between penoxyl radical formed and ferrocene
unit. The compounds 1, 3, 5 bearing 2,6-di-tert-butylphenol
are signiﬁcantly more active than the corresponding
phenyl analogues in the in vitro lipid peroxidation in rat
brain homogenate. N-(3,5-di-tert-butyl-4-hydroxyphenyl)-
iminomethylferrocene (1) performs a promising behavior as
an antioxidant and inhibits the calcium-dependent swelling
of mitochondria. The results allow us to propose the
potential cytoprotective (neuroprotective) eﬀect of ditopic
compounds containing antioxidant 2,6-di-tert-butylphenol
group and redox active ferrocene fragment.
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